Please assess the completion status of the following clinical trial:

Trial Title: Bariatric Atrial Restoration of Sinus Rhythm

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Symptomatic persistent or paroxysmal AF refractory to at least one antiarrhythmic agent~* EF \> 40%~* BMI \> 40 or BMI \> 35 and at least one of the following co-morbidities:~  * Type 2 Diabetes Mellitus (by American Diabetes Association diagnostic criteria).~ * Systolic blood pressure of 130 mmHg and/or diastolic blood pressure 80 mmHg or higher despite medical treatment with maximal doses of three antihypertensive medications).~ * Refractory hyperlipidemia (acceptable levels of lipids unachievable with diet and maximum doses of lipid lowering medications).~ * Obesity-induced cardiomyopathy.~ * Clinically significant obstructive sleep apnea.~ * Obesity-related hypoventilation.~ * Pseudotumor cerebri (documented idiopathic intracerebral hypertension).~ * Severe arthropathy of spine and/or weight-bearing joints (when obesity prohibits appropriate surgical management of joint dysfunction treatable but for the obesity).~ * Hepatic steatosis without evidence of active inflammation.~ * Hypertriglyceridemia~ * Polycystic Ovary Syndrome (PCOS)~ * Asthma~ * Coronary Artery Disease (CAD)~Exclusion Criteria:~* Prior bariatric surgery~* Prior AF catheter ablation~* BMI \> 65 kg/m2~* Contraindication to bariatric surgery or AF ablation~* Contraindication to therapeutic anticoagulation~* Sustained AF lasting more than 3 years~* Left atrial diameter of greater than or equal to 60 mm or LA volume greater than or equal to 60 ml/m2

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Atrial Fibrillation (AF) Catheter Ablation-Group A (Type: ACTIVE_COMPARATOR): Participants will undergo catheter ablation using either radiofrequency or cryo-ablation of pulmonary veins. Participants with persistent AF may also undergo roof and/or floor linear ablation with or without ablation of extra-pulmonary sites at the physician's discretion.
- Bariatric surgery prior to AF Catheter Ablation-Group B (Type: EXPERIMENTAL): Participants will undergo either a Roux-en-Y gastric bypass or a laparoscopic sleeve gastrectomy. The choice of the procedure will be based on numerous factors including current practice, the surgeon's and participant's choice, BMI, and the presence of certain comorbidities and their severity such as GERD, kidney stones, and past surgical history. Participants will undergo standard preoperative evaluation including dietary consultation and psychological evaluation during the eligibility process.~After bariatric surgery, in addition to routine post-surgical management, patients will follow up with cardiologist prior to AF catheter ablation.

Based on this trial design, predict the completion outcome and termination type (if applicable).